HeartBeam (BEAT) Depreciation & Amortization (CF) (2025)
HeartBeam's (BEAT) quarterly Depreciation & Amortization (CF) came in at $16300.0 in Q4 2025.
Powered by 
Analysis
HeartBeam (BEAT) Depreciation & Amortization (CF) (2025) Analysis & Trends
HeartBeam (BEAT) has reported Depreciation & Amortization (CF) for 1 consecutive years, with $16300.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) changed N/A year-over-year to $16300.0 in Q4 2025; TTM through Jun 2026 was $16300.0, a N/A change from a year earlier, with the FY2025 full-year figure at $39500.0, changed N/A from the prior year.
- Depreciation & Amortization (CF) was $16300.0 for Q4 2025 at HeartBeam.
- Over five years, Depreciation & Amortization (CF) peaked at $16300.0 in Q4 2025 and troughed at $16300.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 44.78 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - | - |